flow trial semaglutide renal outcomes 2024 glp-1 receptor agonist kidney results and Cardiovascular Among Patients With CKD Receiving Agonists: A Systematic Review and Meta-Analysis of Randomized Trials Semaglutides Are Poised to Remake – Media Centre | EASD

Mount Sinai, Vitamin B12 deficiency anemia, Niranjan N Singh, Florian P Thomas, Alan L Diamond at al, Vitamin B12-Associated Neurological Diseases, Medscape Mathew, A.R

Understanding whether these effects are direct pharmacological actions or secondary to weight loss remains an important clinical question

GIP also helps with insulin release, but researchers believe that when it works in concert with GLP-1, the combination has a powerful, complementary effect on the body's overall energy balance and how it stores fat

Appetite and Satiety Control: By acting on areas of the brain that regulate appetite, semaglutide helps reduce hunger cues and increases feelings of fullness, making it easier to consume fewer calories and manage cravings

& Dong, Z